Sana to open new CGT manufacturing facility

By The Science Advisory Board staff writers

July 15, 2021 -- Sana Biotechnology has signed a lease to develop a 163,000-sq-ft manufacturing facility in Fremont, CA, to support the manufacture of its late-stage clinical development and early commercial cell and gene therapy (CGT) candidates.

The facility will be designed to provide manufacturing capabilities across the company's portfolio, including allogeneic T cell, viral vector, and pluripotent stem cell production.

The facility's location is in close proximity to Sana's existing technical and scientific capabilities, the firm said. Sana also intends to work with contract manufacturing partners to advance its candidates to the clinic as early as next year.

PerkinElmer to acquire Horizon Discovery for $383M
PerkinElmer has reached an agreement to acquire Horizon Discovery Group with an all-cash offer of approximately $383 million. The transaction is...

Copyright © 2021 scienceboard.net


Conferences
Interphex 2021
October 19-21
New York City, New York United States
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter